Aktis Oncology, Inc. (AKTS) insider trading.
In Q3 2026, insiders at Aktis Oncology, Inc. reported 17 non-derivative transactions on 5 Forms 3, 4 and 5: 0 open-market purchases and 11 sales worth $3.2M.
- Transactions
- 17
- Purchases (P)
- 0
- Sales (S)
- 11
- Net shares, P minus S
- -120,421
- Insiders
- 3
- Last filed
- 2026-09-24
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Czibere Akos | Officer · Chief Medical Officer | 7 | 0 | 5 |
| Herrmann Ken | Director | 6 | 0 | 3 |
| Ron-Bigger Shulamit | Officer · Chief Operating Officer | 4 | 0 | 3 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-23 | Czibere Akos | M (A) | 12,500 | $4.95 | 12,500 | Form 4 |
| 2026-09-23 | Czibere Akos | S (D) | 5,099 | $20.19 | 7,401 | Form 4 |
| 2026-09-23 | Czibere Akos | S (D) | 7,401 | $21.03 | 0 | Form 4 |
| 2026-07-20 | Herrmann Ken | S (D) | 1,350 | $24.56 | 0 | Form 4 |
| 2026-07-20 | Herrmann Ken | S (D) | 3,506 | $24.56 | 1,350 | Form 4 |
| 2026-07-20 | Herrmann Ken | M (A) | 1,350 | $1.91 | 4,856 | Form 4 |
| 2026-07-20 | Herrmann Ken | M (A) | 3,506 | $0.08 | 3,506 | Form 4 |
| 2026-07-17 | Herrmann Ken | M (A) | 3,065 | $0.08 | 3,065 | Form 4 |
| 2026-07-17 | Herrmann Ken | S (D) | 3,065 | $25.21 | 0 | Form 4 |
| 2026-07-08 | Czibere Akos | M (A) | 50,000 | $4.95 | 50,000 | Form 4 |
| 2026-07-08 | Czibere Akos | S (D) | 14,800 | $27.13 | 35,200 | Form 4 |
| 2026-07-08 | Czibere Akos | S (D) | 30,829 | $27.95 | 4,371 | Form 4 |
| 2026-07-08 | Czibere Akos | S (D) | 4,371 | $28.71 | 0 | Form 4 |
| 2026-07-08 | Ron-Bigger Shulamit | S (D) | 4,200 | $28.75 | 0 | Form 4 |
| 2026-07-08 | Ron-Bigger Shulamit | S (D) | 30,000 | $27.94 | 4,200 | Form 4 |
| 2026-07-08 | Ron-Bigger Shulamit | M (A) | 50,000 | $3.66 | 50,000 | Form 4 |
| 2026-07-08 | Ron-Bigger Shulamit | S (D) | 15,800 | $27.13 | 34,200 | Form 4 |
Transaction codes in this quarter
Get AKTS insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=2035832&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · AKTS company page · Aktis Oncology, Inc. on SEC.gov
Questions
Are insiders buying or selling Aktis Oncology, Inc. (AKTS)?
In Q3 2026, insiders at Aktis Oncology, Inc. reported 17 non-derivative transactions on 5 Forms 3, 4 and 5: 0 open-market purchases and 11 sales worth $3.2M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Aktis Oncology, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/akts.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.